Develops portable oxygen concentrators for patients with chronic respiratory conditions. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.
This company is not turning a profit, so the market is pricing its sales instead: 0.4× for every dollar of annual revenue.
Against companies in its own sector, it looks cheaper than 82% of them.
Analysts' average target sits 390% above today's price.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
The price looks reasonable next to what the company earns.
Clearly below the class average.
Clearly below the class average.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
Growth: Sales growth trails the sector average.
An investor who bought at the very peak is down 88% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
The company sells $348.7M a year; the problem isn’t sales — it’s costs running above that number.
It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.
Over the last 12 months, company executives reported 41 buys and 36 sells. Management buying with its own money is usually read as a good sign.
A loss of $22.7M against $348.7M in annual sales.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 22/100.
The growth engine is running at low revs right now. Report-card grade: 22/100.
On our five-subject report card, INGN sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: INGN’s sales are going backwards, and it closed last year at a loss. The road back runs through both.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.
Not covered, because the filings we hold do not carry it: the revenue breakdown.